Evidence map›Paper›PMID 34712829›Full record

ArticleClinical and experimental hepatology2021

Evaluation of interleukin 8 polymorphisms (-251T/A and +781C/T) in patients with hepatocellular carcinoma: a meta-analysis.

Omid Emami Aleagha, Forouzan Moeinzadeh, Seyedeh Farnaz Moeini Shokouh, Erkan Doğan, Masoud Sadeghi

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and experimental hepatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 2 pooled it
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 syntheses or guidelines pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Omid Emami AleaghaMolecular Pathology Research Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Forouzan MoeinzadehDepartment of Medicine, Najafabad Branch, Islamic Azad University, Najafabad, Iran.
Seyedeh Farnaz Moeini ShokouhDepartment of Medicine, Najafabad Branch, Islamic Azad University, Najafabad, Iran.
Erkan DoğanDepartment of Pediatrics, Karabuk University, Faculty of Medicine, Karabuk, Turkey.
Masoud SadeghiDepartment of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Islamic Azad University of Najafabad · IRImam Reza Hospital · IRIslamic Azad University, Science and Research Branch · IRKarabük University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aim of the studyWe reported the association between interleukin 8 ( MATERIAL AND

methodsScopus, PubMed, Web of Science, and Cochrane Library databases were searched until 21 November 2020. The analyses were performed by RevMan 5.3 software using odds ratios (ORs) and 95% confidence intervals (CIs). Also, the analysis of publication bias was performed by CMA 2.0 software.

resultsSearching databases/sources, five articles including ten studies were entered into the meta-analysis. The pooled ORs for

conclusionsThe findings of the meta-analysis showed a lack of significant association between

Indexed as

hepatocellular carcinomainterleukin 8liver cancerpolymorphism

Identifiers

PMID34712829
PMCPMC8527341
OpenAlexW3207096276

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.